| |
ENS@T is the acronym for European Network for the Study of Adrenal
Tumors. This network was founded in 2002 by putting together
three already existing National Adrenal Networks (Comete in
France, GANIMED in Germany, and NISGAT in Italy) and teams from
the United Kingdom all dedicated to the study of adrenal tumors.
|
ENS@T
aims to improve the understanding of the genetics, tumorigenesis
and hypersecretion in patients with adrenal tumors and
syndromes. It aims to improve the prediction of recurrences
and the management of malignant tumors. The study of
these tumors may reveal new molecular mechanisms of
tumor growth and provide insight into the role of peptides
and steroids in hypertension in general.
|
 |
Adrenal
tumors are diverse. They vary in frequency and presentation
and may be inherited and/or aggressive. Most, however,
are rare tumors, and therefore diagnostic and prognostic
cohort studies, as well as therapeutic trials, require
multi-country approaches to increase the number of patients
for each tumor category. ENS@T endeavors to bring together critical masses of expertise
and resources to achieve significant clinical and biological
conclusions and to eventually combat adrenal tumors.
|
